UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Fruzaqla ...

Swiss pharma giant Novartis has announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx (secukinumab ...

The US Food and Drug Administration has granted accelerated approval to sunvozertinib (trade name Zegfrovy) from Dizal ...

The US Food and Drug Administration (FDA) has provided an update on the risk of myocarditis after receiving an mRNA COVID-19 ...

US biopharma Apellis Pharmaceuticals announced a capped royalty purchase agreement with Swedish Orphan Biovitrum where ...

US women’s health focused drugmaker Organon (NYSE: OGN) yesterday revealed disappointing results from the Phase II ELENA ...

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM) is forecast to grow at a compound annual ...

The US Food and Drug Administration (FDA) has granted accelerated approval for Regeneron Pharmaceuticals’ Lynozyfic ...

US biopharma Syntis Bio, which is developing oral therapies for obesity, diabetes and rare diseases, has announced the close ...

Australian neurodegenerative diseases specialist Neurizon Therapeutics has agreed an exclusive global license agreement with ...

US biotech Jazz Pharmaceuticals yesterday announced that the European Commission (EC) has granted conditional marketing ...

A federal judge has blocked the US Department of Health and Human Services from moving forward with a major workforce ...